Company intelligence
IHU RespirERA
Respiratory Health, Environment & Ageing
About IHU RespirERA
Based in Nice and founded in 2023, IHU RespirERA is the only institute entirely dedicated to respiratory health, combining research, care, and training. Our ambition: to reinvent the management of chronic respiratory diseases and lung cancer, by integrating the impacts of aging and environmental factors. As respiratory diseases become an increasingly urgent public health issue worldwide, we offer a comprehensive and innovative approach based on precision medicine. Through cutting-edge technologies, multi-omics data analysis, and strong collaborative dynamics, we develop faster, more accurate diagnostics, more targeted treatments, and personalized care for each patient. By leveraging the exceptional resources of the PACA region and a broad network of scientific, clinical, and industrial partners, IHU RespirERA acts as a true living laboratory to anticipate and address tomorrow’s respiratory challenges.
Verified activity
Signals from IHU RespirERA
3 published signals
Presence & Recognition
IHU RespirERA employee Dr. Fernando Lopez-Rios will present at the AI in the next world of Thoracic Pathology congress on lung cancer biomarker testing and AI implementation
Reported by IHU RespirERA
Presence & Recognition
IHU RespirERA lead thoracic pathologist Jan von der Thüsen will present AI-assisted Lung Cancer Classification and Grading at the AI in the next world of Thoracic Pathology congress on October 6-7, 2026.
Reported by IHU RespirERA
Presence & Recognition
IHU RespirERA launched a speaker introduction series featuring Paul Hofman, Director of the IHU RespirERA, at the AI in the next world of Thoracic Pathology congress.
Reported by IHU RespirERA